Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Psoriasis Treatment Market

Psoriasis Treatment Market Size

Report ID: GMI6129
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Psoriasis Treatment Market Size

Psoriasis Treatment Market size was anticipated to be worth USD 26.5billion in 2022 and is expected to reach USD 60.5 billion by 2032, increasing at an 8.6% CAGR by 2032 due to growing demand for effective and safe treatment options for psoriasis, increasing awareness of psoriasis among the public and healthcare professionals, and increasing research and development in psoriasis treatment.

To get key market trends

Download Free Sample

Moreover, therapeutic device developments, including advanced phototherapy equipment and targeted delivery systems, have improved treatment results for psoriasis patients. These advancements provide more efficient and easy options for treatment.

Psoriasis Treatment Market Report Attributes
Report Attribute	Details
Base Year:	2022
Psoriasis Treatment Market Size in 2022:	USD 26.5 Billion
Forecast Period:	2023-2032
Forecast Period 2023-2032 CAGR:	8.6%
032 Value Projection:	USD 60.5 Billion
Historical Data for:	2018 to 2022
No. of Pages:	248
Tables, Charts & Figures:	428
Segments covered:	Drug class, Type, Route of Administration, Distribution Channel, and Region
Growth Drivers:	Rising prevalence of psoriasis Increasing awareness and improved diagnosis Advancements in psoriasis treatment options Growing geriatric population Growing investments in R&D
Pitfalls & Challenges:	Side effects and safety concerns Limited insurance coverage High cost of treatment

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Psoriasis treatment industry size was USD 26.5 billion in 2022 and will reach USD 60.5 billion by 2032 due to the rising awareness of psoriasis among the public and healthcare professionals.

The plaque psoriasis type segment is expected to record 8.5% CAGR by 2032 owing to the strong desire for effective treatment alternatives.

The hospital pharmacies distribution channel segment held 64.8% share of the market in 2022 due to the ease of access to specialised drugs and therapies in these settings.

North America industry size is expected to reach USD 25 billion by2032 driven by the presence of well-developed and advanced healthcare infrastructure, including hospitals, clinics, research institutions, and pharmaceutical companies.